Breaking Down the Latest Decision in the Purdue Pharma Case

Lowenstein Sandler LLP
Contact
Andrew Behlmann, partner in the firm’s Bankruptcy & Restructuring Department, breaks down last week’s decision by SDNY Judge McMahon to vacate confirmation of Purdue Pharma’s chapter 11 plan. Behlmann discusses the 142-page written opinion as well as the chapter 11 plan’s third-party releases, and provides insightful background on one of the most widely publicized and scrutinized chapter 11 bankruptcy cases in history.

Speakers:

Andrew Behlmann, Partner, Bankruptcy & See more +

Andrew Behlmann, partner in the firm’s Bankruptcy & Restructuring Department, breaks down last week’s decision by SDNY Judge McMahon to vacate confirmation of Purdue Pharma’s chapter 11 plan. Behlmann discusses the 142-page written opinion as well as the chapter 11 plan’s third-party releases, and provides insightful background on one of the most widely publicized and scrutinized chapter 11 bankruptcy cases in history.

Speakers:

Andrew Behlmann, Partner, Bankruptcy & Restructuring Department

Lowenstein Bankruptcy Lowdown

Attorneys in the firm’s Bankruptcy & Restructuring Department break down recent decisions and other key bankruptcy industry news and events. See less -

Embed
Copy

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Lowenstein Sandler LLP | Attorney Advertising

Written by:

Lowenstein Sandler LLP
Contact
more
less

Lowenstein Sandler LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide